Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study-Reference-Cited by-同舟云学术

Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study

Published:2012-06 Issue:5 Volume:18 Page:488-493
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Elmer Lawrence W.,Surmann Erwin,Boroojerdi Babak,Jankovic Joseph

Funder

GlaxoSmithKline and Teva Neuroscience

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference26 articles.

1. New considerations in the medical management of early Parkinson’s disease: impact of recent clinical trials on treatment strategy;Hauser;Parkinsonism Relat Disord,2009

2. Evolution of motor fluctuations in Parkinson’s disease: a longitudinal study over 6 years;Reardon;Mov Disord,1999

3. Current status of symptomatic medical therapy in Parkinson’s disease;Factor;Neurotherapeutics,2008

4. Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations;Jankovic;Mov Disord,2005

5. A novel dopamine agonist for the transdermal treatment of Parkinson’s disease;Jenner;Neurology,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Levodopa versus levodopa sparing in early parkinson�s disease: can we meet halfway?;Revista de investigaci�n Cl�nica;2024-07-12

2. Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders;Pharmaceutical Research;2024-06

3. Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease;Current Neuropharmacology;2023-05

4. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders;Seminars in Cancer Biology;2022-11

5. Excessive Daytime Sleepiness in Parkinson’s Disease;Nature and Science of Sleep;2022-09